Eric Groen
Fortune : 687 834 $ au 31/07/2026
Fortune : 687 834 $ au 31/07/2026
Eric Groen is currently Secretary & Chief Compliance Officer at Genelux Corp.
since 2025.
Formerly, Mr. Groen was Regional General Counsel at Amgen, Inc. and General Counsel at Rani Therapeutics Holdings, Inc. Education includes undergraduate studies at the University of California, Santa Barbara and graduate studies at Harvard Law School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GENELUX CORP. 0,52 % | 16/06/2026 | 233 957 ( 0,52 % ) | 687 834 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GENELUX CORPORATION | Compliance Officer | 01/07/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | - |
| RANI THERAPEUTICS HOLDINGS, INC. | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
University of California, Santa Barbara
University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Law School
Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national